Cleared Special

K984141 - GBACT + KIT

K984141 is an FDA 510(k) clearance for GBACT + KIT, manufactured by Sienco, Inc.. The device is a Class 2 Hematology device with product code JBP cleared through the Special 510(k) pathway after a 191-day FDA review.

K984141 · Sienco, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1999
Decision
191d
Days
Class 2
Risk

K984141 is an FDA 510(k) clearance for the GBACT + KIT. Classified as Activated Whole Blood Clotting Time (product code JBP), Class II - Special Controls.

Submitted by Sienco, Inc. (Wheatridge, US). The FDA issued a Cleared decision on May 28, 1999 after a review of 191 days - an extended review cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.7140 - the FDA hematology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Sienco, Inc. devices

FDA 510(k) Submission Details - K984141

510(k) Number K984141 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 18, 1998
Decision Date May 28, 1999
Days to Decision 191 days
Submission Type Special
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
78d slower than avg
Panel avg: 113d · This submission: 191d
Pathway characteristics
Modification to existing cleared device.

JBP Device Classification - Class 2, Special Controls

Product Code JBP Activated Whole Blood Clotting Time
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.7140
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - JBP Activated Whole Blood Clotting Time

All 18
Devices cleared under the same product code (JBP) and FDA review panel - the closest regulatory comparables to K984141.
(TAS) LOW RANGE HEPARIN MANAGEMENT CARD RAPIDPOINT
K994194 · Cardiovascular Diagnostics, Inc. · Mar 2000
I-STAT SYSTEM
K992571 · I-Stat Corp. · Feb 2000
ACT TEST CATRIDGES FOR COAGUCHEK PRO SYSTEM, ACT CONTROLS FOR COAGUCHEK PRO SYSTEM
K992851 · Roche Diagnostics Corp. · Jan 2000
MAX-ACT
K983649 · Array Medical, Inc. · Dec 1998
B&D ACTIVATED CLOTTING TIME (ACT) TEST TUBES BD-C101 (DIATOMACEOUS EARTH) AND BD-K101 (KAOLIN)
K971935 · B & D Corp. · Oct 1997
ACTALYKE ACTIVATED CLOTTING TIME TEST SYSTEM/CLOTTING TIME TUBES/WHOLE BLOOD QC KIT/ACTALYKE ELECTRONIC CLOTTING TUBE
K964609 · Array Medical, Inc. · Mar 1997